New Avodart Study

[wallace911]

Is this new? It was entered only a month ago ...

http://clinicaltrials.gov/ct2/show/NCT0 ... 22&rank=14

Estimated Enrollment: 900
Study Start Date: January 2010
Estimated Study Completion Date: July 2013

Oke look at my post below ... this is clearly another one now to check long term safety. Good sign I guess. And am I right that those guys in Korea already prescribe it anyways???

I am surprised how many other studies are seemingly going on there anyways ... :

http://clinicaltrials.gov/ct2/results?c ... lopecia%22

 

[wallace911]

Further study details as provided by GlaxoSmithKline:

Primary Outcome Measures:

Occurrence of adverse event after AVODAR® administration [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:

Effectiveness after AVODAR® administration [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Occurrence of unexpected or serious adverse event after AVODAR® administration [ Time Frame: 2 years ] [ Designated as safety issue: Yes ]

Basically there is no treatment allocation. Subjects who would be administered of AVODAR® at their physicians' discretion will be enrolled. Dosage regimen will be recommended according to the prescribing information. Subjects will be enrolled consecutively.

 

[zayin]

Cool. it does show that Glaxo is still investigating dutasteride for hairloss. They did a phase III (but it was more a phase II trial) and effectiveness of dutasteride was better than control but not that much! So that was really dissapointing. I am suprised that they call this a trial, whereas in fact it is a kind of cohort study.